| Literature DB >> 34944205 |
Janghan Choi1, Hanseo Ko1, Yuguo Hou Tompkins1, Po-Yun Teng1, Jeferson M Lourenco2, Todd R Callaway2, Woo Kyun Kim1.
Abstract
The purpose of the study was to investigate effects of different inoculation dosages of E. tenella on growth performance, gastrointestinal permeability, oocyst shedding, intestinal morphology, fecal consistency, ileal apparent digestibility, antioxidant capacity, and cecal VFA profile in broiler chickens. Five different dosages (T0: 0, T1: 6250, T2: 12,500, T3: 25,000, and T4: 50,000) of E. tenella oocysts were inoculated via oral gavage to fourteen-day-old broilers. Inoculation of E. tenella linearly increased FCR (p < 0.05), and feed intake was quadratically increased on 6 days post-infection (dpi; p = 0.08) and 7 dpi (p = 0.09). Cecal lesion score of each treatment was T0: 0; T1: 0.39 ± 0.14; T2: 0.93 ± 0.21; T3: 1.25 ± 0.16; and T4: 1.58 ± 0.2. Cecal total VFA production was linearly reduced due to E. tenella infection on 6 dpi (p < 0.01). E. tenella infection deepened cecal crypts depth on 6 dpi (CD; p < 0.05). Gastrointestinal permeability tended to be linearly increased (p = 0.07). E. tenella infection tended to linearly reduce duodenal VH (p = 0.1) and jejunal VH on 9 dpi (p = 0.09). Different dosages of E. tenella modulated the tendency of fecal moisture content and oocyst shedding. Therefore, E. tenella infection impaired feed efficiency and small intestinal health mainly by reducing cecal VFA production and deepening cecal CD in broilers.Entities:
Keywords: Eimeria tenella; broiler chickens; cecal health; feed efficiency; oocyst shedding; volatile fatty acids
Year: 2021 PMID: 34944205 PMCID: PMC8697946 DOI: 10.3390/ani11123428
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Diet composition and calculated analysis of the broiler diet (g/kg, as fed basis).
| Ingredients | D 14 to 23 |
|---|---|
| Corn | 700.8 |
| Soybean meal (480 g crude protein/kg) | 241.73 |
| Soybean oil | 15.84 |
| Deflour phosphate | 13.99 |
| Sand | 7.00 |
| Limestone | 6.11 |
| Titanium dioxide | 3.00 |
| DL-Methionine 99% | 2.86 |
| L-Lysine HCl 78% | 2.80 |
| Vitamin Premix 1 | 2.50 |
| Common Salt | 1.79 |
| L-threonine | 0.77 |
| Mineral Premix 2 | 0.80 |
| Total | 1,000 |
| Calculated energy and nutrient value, % | |
| Metabolizable energy, Mcal/kg | 3,100 |
| Crude protein | 18.375 |
| SID 3 Methionine | 0.552 |
| SID Total sulfur amino acids | 0.8 |
| SID Lysine | 1.02 |
| SID Threonine | 0.66 |
| Total calcium | 0.76 |
| Available phosphate | 0.38 |
1 Vitamin mix provided the following in mg/100 g diet: thiamine-HCl, 1.5; riboflavin 1.5; nicotinic acid amide 15; folic acid 7.5; pyridoxine-HCl, 1.2; d-biotin 3; vitamin B-12 (source concentration, 0.1%) 2; d-calcium pantothenate 4; menadione sodium bisulfite, 1.98; α-tocopherol acetate (source 500,000 IU/g), 22.8; cholecalciferol (source 5,000,000 IU/g) 0.09; retinyl palmitate (source 500,000 IU/g), 2.8; ethoxyquin, 13.34; I-inositol, 2.5; dextrose, 762.2; 2 Mineral mix provided the following in g/100 g diet: Ca(H2PO4)2·H2O, 3.62; CaCO3, 1.48; KH2PO4, 1.00; Na2SeO4, 0.0002; MnSO4·H2O, 0.035; FeSO4·7H2O, 0.05; MgSO4·7H2O, 0.62; KIO3, 0.001; NaCl, 0.60; CuSO4·5H2O, 0.008; ZnCO3, 0.015; CoCl2·6H2O, 0.00032; NaMoO4·2H2O, 0.0011; KCl, 0.10; dextrose, 0.40; 3 SID: standard ileal digestible amino acid.
Growth performance parameters including body weight (BW; g), average daily gain (ADG; g/d), average daily feed intake (ADFI; g/d), and feed conversion ratio (FCR; g/g) of broiler chickens infected with different dosages of Eimeria tenella during the acute phase [0 to 6 days post-infection (dpi)] and recovery phase (6 to 9 dpi) 1.
| Items | Polynomial Contrast | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | SEM | Lin. | Quad. | ||
| Initial BW | 359.4 | 360.3 | 356 | 359.5 | 358 | 3.72 | 0.38 | ||
| 0 to 6 dpi | |||||||||
| BW | 703.4 | 705.5 | 697 | 699.5 | 680.77 | 27.28 | 0.55 | 0.16 | 0.43 |
| ADG | 57.33 | 57.53 | 57.01 | 56.54 | 53.80 | 4.32 | 0.56 | 0.16 | 0.37 |
| ADFI | 84.92 | 87.24 | 88.63 | 86.05 | 84.31 | 4.61 | 0.55 | 0.69 | 0.11 |
| FCR | 1.48 | 1.52 | 1.55 | 1.52 | 1.57 | 0.06 | 0.19 | 0.04 | 0.64 |
| 6 to 9 dpi | |||||||||
| BW | 881.8 | 859 | 876.9 | 885.73 | 889.19 | 79.63 | 0.97 | 0.69 | 0.72 |
| ADG | 65.81 | 57.40 | 61.68 | 63.83 | 69.70 | 13.74 | 0.62 | 0.43 | 0.22 |
| ADFI | 115.4 | 120.9 | 123.77 | 123.1 | 123.1 | 14.86 | 0.87 | 0.4 | 0.55 |
| FCR | 1.9 | 2.17 | 2.03 | 1.97 | 1.77 | 0.39 | 0.50 | 0.38 | 0.16 |
| 0 to 9 dpi | |||||||||
| ADG | 60.16 | 57.49 | 58.83 | 58.97 | 59.10 | 6.47 | 0.97 | 0.94 | 0.66 |
| ADFI | 95.09 | 98.47 | 100.6 | 98.16 | 97.24 | 6.81 | 0.72 | 0.65 | 0.22 |
| FCR | 1.62 | 1.74 | 1.71 | 1.67 | 1.64 | 0.14 | 0.54 | 0.85 | 0.15 |
1 T0: treatment 0 (Sham-challenged with phosphate-buffered saline); T1, treatment 1 (challenged with 6250 sporulated oocysts of Eimeria tenella); T2, treatment 2 (challenged with 12,500 sporulated oocysts of Eimeria tenella); T3, treatment 3 (challenged with 25,000 sporulated oocysts of Eimeria tenella); T4, treatment 4 (challenged with 50,000 sporulated oocysts of Eimeria tenella). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Figure 1Daily feed intake of broiler chickens infected with different dosages of Eimeria tenella. Daily feed intake was measured in the T0 (treatment 0; Sham-challenged with phosphate-buffered saline); T1 (treatment 1; challenged with 6250 sporulated oocysts of E. tenella); T2 (treatment 2; challenged with 12,500 sporulated oocysts of E. tenella); T3 (treatment 3; challenged with 25,000 sporulated oocysts of E. tenella); T4 (treatment 4; challenged with 50,000 sporulated oocysts of E. tenella) groups during 1 to 9 days post-infection. At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Figure 2Cecal lesion score of broiler chickens infected with different dosages of Eimeria tenella on 6 days post-infection. Cecal lesion score was measured in the T0 (treatment 0; Sham-challenged with phosphate-buffered saline); T1 (treatment 1; challenged with 6250 sporulated oocysts of E. tenella); T2 (treatment 2; challenged with 12,500 sporulated oocysts of E. tenella); T3 (treatment 3; challenged with 25,000 sporulated oocysts of E. tenella); T4 (treatment 4; challenged with 50,000 sporulated oocysts of E. tenella) groups on 6 days post-infection. Different letters at the same time point represent significantly different (p < 0.05) by utilizing the Kruskal–Wallis test followed by the Dwass, Steel, Critchlow-Fligner post hoc test.
Figure 3Oocyst shedding of broiler chickens infected with different dosages of Eimeria tenella. Fecal oocyst shedding was measured using McMaster chamber in the T0 (treatment 0; Sham-challenged with phosphate-buffered saline); T1 (treatment 1; challenged with 6250 sporulated oocysts of E. tenella); T2 (treatment 2; challenged with 12,500 sporulated oocysts of E. tenella); T3 (treatment 3; challenged with 25,000 sporulated oocysts of E. tenella); T4 (treatment 4; challenged with 50,000 sporulated oocysts of E. tenella) groups on 5 to 6, 6 to 7, and 7 to 8 days post-infection. Number of E. tenella oocysts is shown as log10 (oocysts/g feces). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments. Different letters at the same time point represent significantly different (p < 0.05) by proc mixed followed by the Tukey’s multiple comparison test among the treatment groups.
Fecal moisture content (fecal consistency) and ileal moisture content of broiler chickens infected with different dosages of Eimeria tenella on 5 to 6 days post-infection (dpi), 6 to 7 dpi, and 7 to 8 dpi (fecal moisture content), and at 6 and 9 dpi (ileal moisture content) 1.
| Items | Polynomial Contrast | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | SEM | Lin. | Quad. | ||
| Feces | |||||||||
| 5 to 6 dpi | 78.23 | 76.76 | 75.91 | 76.56 | 76.99 | 1.66 | 0.22 | 0.22 | 0.04 |
| 6 to 7 dpi | 68.14 | 69.68 | 73.38 | 74.64 | 68.66 | 4.87 | 0.12 | 0.35 | 0.03 |
| 7 to 8 dpi | 70.81 | 71.87 | 73.09 | 75.07 | 74.86 | 2.52 | 0.03 | <0.01 | 0.65 |
| Ileum | |||||||||
| 6 dpi | 81.75 | 81.83 | 80.6 | 80.94 | 80.81 | 0.76 | 0.03 | 0.01 | 0.33 |
| 9 dpi | 80.34 | 80.1 | 81.24 | 80.62 | 79.93 | 1.22 | 0.42 | 0.9 | 0.18 |
1 T0: treatment 0 (Sham-challenged with phosphate-buffered saline); T1, treatment 1 (challenged with 6250 sporulated oocysts of E. tenella); T2, treatment 2 (challenged with 12,500 sporulated oocysts of E. tenella); T3, treatment 3 (challenged with 25,000 sporulated oocysts of E. tenella); T4, treatment 4 (challenged with 50,000 sporulated oocysts of E. tenella). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Figure 4In vivo gastrointestinal permeability of broiler chickens infected with different dosages of Eimeria tenella. In vivo gastrointestinal permeability was measured using fluorescein isothiocyanate dextran 4 kDa in the T0 (treatment 0; Sham-challenged with phosphate-buffered saline); T1 (treatment 1; challenged with 6250 sporulated oocysts of E. tenella); T2 (treatment 2; challenged with 12,500 sporulated oocysts of E. tenella); T3 (treatment 3; challenged with 25,000 sporulated oocysts of E. tenella); T4 (treatment 4; challenged with 50,000 sporulated oocysts of E. tenella) groups on 5, 6, and 7 days post-infection. At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Duodenal, jejunal, ileal, and cecal morphology [villus height (VH; μm), crypts depth (CD; μm), and VH:CD] of broiler chickens infected with different dosages of Eimeria tenella on 6 days post-infection (dpi) and 9 dpi 1.
| Items | Polynomial Contrast | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | SEM | Lin. | Quad. | ||
| 6 dpi | |||||||||
| Duodenum | |||||||||
| VH | 2459.97 | 2585.52 | 2442.42 | 2154.12 | 2485.42 | 300.16 | 0.22 | 0.34 | 0.56 |
| CD | 282.46 | 245.17 | 253.82 | 227.51 | 255.55 | 35.36 | 0.17 | 0.13 | 0.08 |
| VH:CD | 9.05 | 10.8 | 9.86 | 10.39 | 9.85 | 1.78 | 0.53 | 0.61 | 0.26 |
| Jejunum | |||||||||
| VH | 1411.46 | 1375.62 | 1332.65 | 1321.93 | 1303.21 | 147 | 0.71 | 0.17 | 0.76 |
| CD | 234.92 | 222.03 | 223.93 | 221.29 | 225.43 | 34.52 | 34.52 | 0.66 | 0.57 |
| VH:CD | 6.38 | 6.56 | 6.08 | 6.28 | 5.94 | 1.22 | 0.91 | 0.47 | 0.85 |
| Ileum | |||||||||
| VH | 899.01 | 936.51 | 934.37 | 894.06 | 879.21 | 113.9 | 0.87 | 0.58 | 0.41 |
| CD | 194.11 | 181.49 | 183.02 | 184.97 | 161.46 | 24.03 | 0.24 | 0.06 | 0.59 |
| VH:CD | 4.92 | 5.28 | 5.18 | 5.09 | 5.72 | 0.59 | 0.22 | 0.08 | 0.54 |
| Cecal CD | 217.21 b | 410.22 a | 451.86 a | 593.18 a | 477.05 a | 111.85 | <0.01 | <0.01 | <0.01 |
| 9 dpi | |||||||||
| Duodenum | |||||||||
| VH | 2475 | 2574.81 | 2452.6 | 2150.15 | 2375.54 | 278.63 | 0.17 | 0.1 | 0.87 |
| CD | 250.69 | 226.78 | 233.48 | 211.26 | 234.56 | 35.58 | 0.49 | 0.31 | 0.23 |
| VH:CD | 10.26 | 11.55 | 11.04 | 10.74 | 10.32 | 1.95 | 0.77 | 0.78 | 0.28 |
| Jejunum | |||||||||
| VH | 1410.12 | 1348.81 | 1320.96 | 1288.44 | 1257.51 | 159.32 | 0.54 | 0.09 | 0.82 |
| CD | 208.29 | 217.18 | 197.49 | 211.8 | 210.85 | 34.22 | 0.87 | 0.99 | 0.78 |
| VH:CD | 7.21 | 6.55 | 7.06 | 6.5 | 6.21 | 1.86 | 0.69 | 0.26 | 0.87 |
| Ileum | |||||||||
| VH | 888.68 | 917.4 | 879.2 | 885.43 | 876.32 | 108.22 | 0.97 | 0.69 | 0.85 |
| CD | 173.99 | 167.73 | 158.63 | 161.9 | 155.46 | 28.8 | 0.8 | 0.26 | 0.78 |
| VH:CD | 5.35 | 5.57 | 5.74 | 5.7 | 5.95 | 0.72 | 0.69 | 0.17 | 0.89 |
| Cecal CD | 87.57 b | 163.55 a,b | 182.47 a | 224.19 a | 196.3 a | 47.71 | <0.01 | <0.01 | 0.02 |
1 T0: treatment 0 (Sham-challenged with phosphate-buffered saline); T1, treatment 1 (challenged with 6250 sporulated oocysts of E. tenella); T2, treatment 2 (challenged with 12,500 sporulated oocysts of E. tenella); T3, treatment 3 (challenged with 25,000 sporulated oocysts of E. tenella); T4, treatment 4 (challenged with 50,000 sporulated oocysts of E. tenella). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments. Different letters at the same time point represent significantly different (p < 0.05) by proc mixed followed by the Tukey’s multiple comparison test among the treatment groups.
Figure 5Ceca morphology of a non-challenged bird ((A) 2×; (B) 10×) and of a Eimeria tenella infected bird ((C) 2×; (D) 10×) in the T1 group (challenged with 6250 sporulated oocysts of E. tenella) on 6 days post-infection when tissues were stained with hematoxylin and eosin. Microgametocytes, macrogametocytes, and schizonts were observed in the ceca crypts (E,F).
Apparent ileal digestibility (%) of dry matter (DM), organic matter (OM), and ash of broiler chickens infected with different dosages of Eimeria tenella on 6 days post-infection (dpi) and 9 dpi.
| Items | Polynomial Contrast | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | SEM | Lin. | Quad. | ||
| 6 dpi | |||||||||
| DM | 69.16 | 70.31 | 68.35 | 71.53 | 70.19 | 1.96 | 0.09 | 0.21 | 0.96 |
| OM | 70.85 | 72.08 | 70.13 | 73.32 | 71.79 | 1.94 | 0.09 | 0.23 | 0.89 |
| Ash | 40.16 | 40 | 37.66 | 40.82 | 42.66 | 5.47 | 0.6 | 0.42 | 0.26 |
| 9 dpi | |||||||||
| DM | 72.71 | 70.31 | 71.86 | 72.44 | 73.5 | 2.8 | 0.42 | 0.36 | 0.2 |
| OM | 75.02 | 72.29 | 74.32 | 74.68 | 75.8 | 2.69 | 0.29 | 0.31 | 0.18 |
| Ash | 33.03 | 36.24 | 29.47 | 33.86 | 33.82 | 9.49 | 0.81 | 0.95 | 0.76 |
1 T0: treatment 0 (Sham-challenged with phosphate-buffered saline); T1, treatment 1 (challenged with 6250 sporulated oocysts of E. tenella); T2, treatment 2 (challenged with 12,500 sporulated oocysts of E. tenella); T3, treatment 3 (challenged with 25,000 sporulated oocysts of E. tenella); T4, treatment 4 (challenged with 50,000 sporulated oocysts of E. tenella). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Figure 6Total antioxidant capacity in the liver of broiler chickens infected with different dosages of Eimeria tenella. On 6 and 9 days post-infection (dpi), total antioxidant capacity in the liver was measured in the T0 (treatment 0; Sham-challenged with phosphate-buffered saline); T1 (treatment 1; challenged with 6250 sporulated oocysts of E. tenella); T2 (treatment 2; challenged with 12,500 sporulated oocysts of E. tenella); T3 (treatment 3; challenged with 25,000 sporulated oocysts of E. tenella); T4 (treatment 4; challenged with 50,000 sporulated oocysts of E. tenella) groups. At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments.
Concentrations of volatile fatty acids (mM) in ceca contents of broiler chickens infected with different dosages of Eimeria tenella at 6 days post-infection (dpi) and 9 dpi 1.
| Items | Polynomial Contrast | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| T0 | T1 | T2 | T3 | T4 | SEM | Lin. | Quad. | ||
| 6 dpi | |||||||||
| Acetate | 48.21 a | 35.2 a,b | 35.64 a,b | 36.94 a,b | 26.91 b | 10 | 0.02 | <0.01 | 0.65 |
| Propionate | 8.37 | 9.03 | 0.84 | 7.27 | 6.1 | 2.95 | 0.5 | 0.11 | 0.45 |
| Isobutyrate | 0.26 | 0.17 | 0.19 | 0.15 | 0.12 | 0.08 | 0.07 | <0.01 | 00.73 |
| Butyrate | 8.69 | 5.8 | 7.4 | 5.34 | 4.96 | 3.8 | 0.42 | 0.12 | 0.82 |
| Isovalerate | 0.42 | 0.42 | 0.45 | 0.32 | 0.37 | 0.17 | 0.72 | 0.35 | 0.82 |
| Valerate | 1.09 | 0.95 | 0.78 | 0.69 | 0.8 | 0.51 | 0.72 | 0.22 | 0.47 |
| Total VFA | 67.04 a | 51.58 a,b | 52.52 a,b | 50.73 a,b | 39.26 b | 13.95 | 0.04 | <0.01 | 0.8 |
| 9 dpi | |||||||||
| Acetate | 50.77 | 76.52 | 62.01 | 46.47 | 48.11 | 27.04 | 0.31 | 0.32 | 0.25 |
| Propionate | 6.14 b | 11.87 a | 8.17 a,b | 7.82 a,b | 7.07 a,b | 3.34 | 0.06 | 0.62 | 0.07 |
| Isobutyrate | 0.16 | 0.32 | 0.15 | 0.16 | 0.16 | 0.14 | 0.22 | 0.39 | 0.55 |
| Butyrate | 8.64 | 13.04 | 8.58 | 6.24 | 6.3 | 4.94 | 0.16 | 0.09 | 0.4 |
| Isovalerate | 0.26 | 0.53 | 0.39 | 0.37 | 0.6 | 0.39 | 0.59 | 0.31 | 0.96 |
| Valerate | 0.96 a,b | 1.65 a | 0.86 a,b | 0.8 a,b | 0.57 b | 0.55 | 0.03 | 0.03 | 0.21 |
| Total VFA | 66.94 | 103.94 | 68.72 | 61.86 | 62.83 | 35.97 | 0.26 | 0.29 | 0.43 |
1 T0: treatment 0 (Sham-challenged with phosphate-buffered saline); T1, treatment 1 (challenged with 6250 sporulated oocysts of E. tenella); T2, treatment 2 (challenged with 12,500 sporulated oocysts of E. tenella); T3, treatment 3 (challenged with 25,000 sporulated oocysts of E. tenella); T4, treatment 4 (challenged with 50,000 sporulated oocysts of E. tenella). At each time point, orthogonal polynomial contrasts analysis was conducted to see linear pattern (L) and quadratic pattern (Q) among the treatments. Different letters at the same time point represent significantly different (p < 0.05) by proc mixed followed by the Tukey’s multiple comparison test among the treatment groups.